Skip to Main Content

Author Details

Young K Song
National Cancer Institute, National Institutes of Health
2007
90
30
PMIDPaper TitleJournal TitlePublished Year
36607839A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia.Blood Adv2023
37732905Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity.Cancer Res Commun2023
37774704Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.Cell Rep Med2023
36607839A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia.Blood Adv2023
37291054The role of myokines in cancer: crosstalk between skeletal muscle and tumor.BMB Rep2023
37774704Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.Cell Rep Med2023
37732905Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity.Cancer Res Commun2023
37291054The role of myokines in cancer: crosstalk between skeletal muscle and tumor.BMB Rep2023
34826187JNK-mediated Ser27 phosphorylation and stabilization of SIRT1 promote growth and progression of colon cancer through deacetylation-dependent activation of Snail.Mol Oncol2022
35852863An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma.J Clin Invest2022
35465663Dentithecamides A-H, Diacylated Zoanthoxanthin Derivatives with PAX3-FOXO1 Inhibitory Activity from the Hydroid <i>Dentitheca habereri</i>.J Nat Prod2022
34826187JNK-mediated Ser27 phosphorylation and stabilization of SIRT1 promote growth and progression of colon cancer through deacetylation-dependent activation of Snail.Mol Oncol2022
35110423Direct Contact with Platelets Induces Podoplanin Expression and Invasion in Human Oral Squamous Cell Carcinoma Cells.Biomol Ther (Seoul)2022
35121655IKKα-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines.Proc Natl Acad Sci U S A2022
35465663Dentithecamides A-H, Diacylated Zoanthoxanthin Derivatives with PAX3-FOXO1 Inhibitory Activity from the Hydroid <i>Dentitheca habereri</i>.J Nat Prod2022
35852863An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma.J Clin Invest2022
35121655IKKα-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines.Proc Natl Acad Sci U S A2022
35110423Direct Contact with Platelets Induces Podoplanin Expression and Invasion in Human Oral Squamous Cell Carcinoma Cells.Biomol Ther (Seoul)2022
32843585Thymoquinone Suppresses Migration of Human Renal Carcinoma Caki-1 Cells through Inhibition of the PGE<sub>2</sub>-Mediated Activation of the EP2 Receptor Pathway.Biomol Ther (Seoul)2021
34166060Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.J Clin Oncol2021
33468559Genome-Wide Analysis Unveils DNA Helicase RECQ1 as a Regulator of Estrogen Response Pathway in Breast Cancer Cells.Mol Cell Biol2021
33520712Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy.Front Oncol2021
33766523IL-1β induces expression of proinflammatory cytokines and migration of human colon cancer cells through upregulation of SIRT1.Arch Biochem Biophys2021
33924899Oral-Gut Microbiome Axis in Gastrointestinal Disease and Cancer.Cancers (Basel)2021
32843585Thymoquinone Suppresses Migration of Human Renal Carcinoma Caki-1 Cells through Inhibition of the PGE<sub>2</sub>-Mediated Activation of the EP2 Receptor Pathway.Biomol Ther (Seoul)2021
33420019Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma.Nat Commun2021
34987523Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment.Front Immunol2021
34836971BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma.Nat Commun2021
34485806Report of Canonical <i>BCR</i>-<i>ABL1</i> Fusion in Glioblastoma.JCO Precis Oncol2021
34885201Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse Gliomas.Cancers (Basel)2021
34818552Immuno-transcriptomic profiling of extracranial pediatric solid malignancies.Cell Rep2021
33520712Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy.Front Oncol2021
33766523IL-1β induces expression of proinflammatory cytokines and migration of human colon cancer cells through upregulation of SIRT1.Arch Biochem Biophys2021
33924899Oral-Gut Microbiome Axis in Gastrointestinal Disease and Cancer.Cancers (Basel)2021
34885201Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse Gliomas.Cancers (Basel)2021
34987523Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment.Front Immunol2021
34818552Immuno-transcriptomic profiling of extracranial pediatric solid malignancies.Cell Rep2021
34485806Report of Canonical <i>BCR</i>-<i>ABL1</i> Fusion in Glioblastoma.JCO Precis Oncol2021
34836971BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma.Nat Commun2021
34166060Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.J Clin Oncol2021
33420019Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma.Nat Commun2021
33468559Genome-Wide Analysis Unveils DNA Helicase RECQ1 as a Regulator of Estrogen Response Pathway in Breast Cancer Cells.Mol Cell Biol2021
32165235Thymoquinone induces apoptosis of human renal carcinoma Caki-1 cells by inhibiting JAK2/STAT3 through pro-oxidant effect.Food Chem Toxicol2020
32325994Chemerin Treatment Inhibits the Growth and Bone Invasion of Breast Cancer Cells.Int J Mol Sci2020
32416589Miswired Enhancer Logic Drives a Cancer of the Muscle Lineage.iScience2020
32165235Thymoquinone induces apoptosis of human renal carcinoma Caki-1 cells by inhibiting JAK2/STAT3 through pro-oxidant effect.Food Chem Toxicol2020
32276460ERK Dephosphorylation through MKP1 Deacetylation by SIRT1 Attenuates RAS-Driven Tumorigenesis.Cancers (Basel)2020
32152202Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2.Clin Cancer Res2020
33246985Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemia.J Immunother Cancer2020
32744500NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.Elife2020
  • 1 - 50 of 180

Recommended Authors

Tuo Zhang
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 0
Jimin Shin
Sungkyunkwan University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 1
Guo Chen
China Pharmaceutical University
Career Start Year 2009
Number of shared co-authors 5
Rahul Kumar
Roswell Park Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Liang Liang
Tangdu Hospital, Fourth Military Medical University
Career Start Year 2006
Number of shared co-authors 0
Guan Wang
Jilin University
Career Start Year 2005
Number of shared co-authors 0
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 0
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 1
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 0
Bin Yan
The University of Hong Kong
Career Start Year 2003
Number of shared co-authors 4
Andrew V Kossenkov
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 2
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 0
Hye Jin You
Research Institute, National Cancer Center
Career Start Year 2000
Number of shared co-authors 0
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 8
Ming Zhan
Ningbo First Hospital, Zhejiang University
Career Start Year 2000
Number of shared co-authors 1
Yan Liu
Chengdu Medical College
Career Start Year 1999
Number of shared co-authors 0
Krishna P Bhat
Department of Neurosurgery at the University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 1
Bing-Hung Chen
Kaohsiung Medical University
Career Start Year 1998
Number of shared co-authors 9
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Na Zhang
Obstetrics and Gynecology Hospital of Fudan University
Career Start Year 1997
Number of shared co-authors 0
Erxi Wu
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 0
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 4
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 1
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 4
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 0
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 2
Mingyao Liu
The Institute of Biomedical Sciences, East China Normal University
Career Start Year 1994
Number of shared co-authors 1
Sun Young Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1988
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 6

Collaborators

Javed Khan
Center for Cancer Research, National Cancer Institute
Co-authored papers 49
Jun S Wei
Center for Cancer Research, National Cancer Institute
Co-authored papers 36
Jack F Shern
Co-authored papers 14
Qing-Rong Chen
Center for Biomedical Informatics and Information Technology
Co-authored papers 12
Yinling Hu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 7
Jami Willette-Brown
Center for Cancer Research, National Cancer Institute
Co-authored papers 6
Feng Zhu
Basic Medical College, Qingdao University
Co-authored papers 6
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers 6
Xiaolin Wu
Leidos Biomedical Research Inc.
Co-authored papers 4
Frederic G Barr
Center for Cancer Research
Co-authored papers 4
John M Maris
Children's Hospital of Philadelphia
Co-authored papers 3
Craig J Thomas
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Douglas S Hawkins
Co-authored papers 3
Arnulfo Mendoza
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Rajarshi Guha
Vertex Pharmaceuticals
Co-authored papers 3
David S Schrump
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
William A Weiss
University of California san francisco
Co-authored papers 3
Kenneth Aldape
National Cancer Institute
Co-authored papers 3
Beat W Sch??fer
Department of Oncology and Children's Research Center, University Children's Hospital
Co-authored papers 3
Zhonghe Sun
Jiangsu University
Co-authored papers 3
Peter J Houghton
The University of Texas Health Science Center at San Antonio
Co-authored papers 3
Marc Ferrer
National Institutes of Health, National Center for Advancing Translational Sciences
Co-authored papers 3
Sandra Burkett
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Jaime M Guidry Auvil
National Cancer Institute
Co-authored papers 2
Sichuan Xi
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Markku Miettinen
National Cancer Institute
Co-authored papers 2
Kevin Camphausen
National Cancer Institute
Co-authored papers 2
Xiaohu Zhang
National Center for Advancing Translational Sciences
Co-authored papers 2
Zied Abdullaev
Co-authored papers 2
Release 1.2